Sage Therapeutics Inc (NASDAQ:SAGE) is up 37.5% premarket, after news of Biogen's (BIIB) proposed takeover. Late Friday, the biopharmaceutical name said it would carefully review the unsolicited $422 ...
US stock futures slipped on Wednesday as investors absorbed a report that President-elect Donald Trump is considering declaring a national economic emergency to pave the way for proposed tariffs.